3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
9
Triple Negative Breast Neoplasms
2
Neoplasms
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
HER2-positive Breast Cancer
2
Colorectal Neoplasms
2
Stomach Neoplasms
1
Rectal Neoplasms
1
Pathologic Complete Response
1
Hemangiosarcoma
1
HER2-positive Metastatic Breast Cancer
1
Brain Neoplasms
1
Anatomic Stage II Breast Cancer AJCC v8
1
Adenocarcinoma
1
Interventions
Magnetic Resonance Spectroscopy
2
sapanisertib
1
pertuzumab
1
patritumab deruxtecan
1
gadopiclenol
1
gadobutrol
1
fludarabine phosphate
1
fludarabine
1
aldesleukin
1
Trastuzumab
1
Spinal Puncture
1
Specimen Handling
1
Radiotherapy
1
Nivolumab
1
Methotrexate
1
Mesna
1
Interleukin-2
1
Cyclophosphamide
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Meningeal Neoplasms
×
tucatinib
×
90 days
×
Clear all
No trials found.